Glòria Garrabou
Research group
- Inherited Metabolic Diseases and Muscular Disorders Group leader (R4-UB)
About me
Dr. Gloria Garrabou, a professor at the Faculty of Medicine and Health Sciences of UB, leads a highly translational biomedical research laboratory, patient-centered, closely linked to the clinical and teaching activities of the team. Her research group, accredited by the Generalitat de Catalunya, is affiliated with prestigious institutions such as IDIBAPS, CIBERER, and UB (Campus Clínic). Her focus is on the study of rare diseases, mostly metabolic or muscular, combining the use of high-performance OMICS tools, functional tests, and state-of-the-art disease models. She participates in 6 clinical trials and in the drafting of clinical guidelines. She is a member of societies such as SSIEM and eMIT and collaborates with interdisciplinary XUEC/CSUR units for the transfer and care of patients
Featured publications
-
Integrated Multi-Omics Analysis for Inferring Molecular Players in Inclusion Body Myositis
Authors:Reference: Antioxidants 2023. -
Unravelling inclusion body myositis using a patient-derived fibroblast model
Authors:Reference: Journal Of Cachexia Sarcopenia And Muscle 2023. -
Multicentric Standardization of Protocols for the Diagnosis of Human Mitochondrial Respiratory Chain Defects
Authors:Reference: Antioxidants 2022. -
Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes Mellitus
Authors:Reference: Antioxidants 2020. -
The impact of mitochondrial deficiencies in neuromuscular diseases
Authors:Reference: Antioxidants 2020. -
Mitochondrial Toxicogenomics for Antiretroviral Management: HIV Post-exposure Prophylaxis in Uninfected Patients
Authors:Reference: Frontiers In Genetics 2020. -
Bioenergetics and Autophagic Imbalance in Patients-Derived Cell Models of Parkinson Disease Supports Systemic Dysfunction in Neurodegeneration
Authors:Reference: Frontiers In Neuroscience 2019. -
Mitochondrial implications in human pregnancies with intrauterine growth restriction and associated cardiac remodelling
Authors:Reference: Journal Of Cellular And Molecular Medicine 2019. -
Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2 G2019S -Parkinson's disease
Authors:Reference: Journal Of Translational Medicine 2018. -
Transcriptional alterations in skin fibroblasts from Parkinson's disease patients with parkin mutations
Authors:Reference: Neurobiology Of Aging 2018.
Featured Projects
-
Impacto nuclear sobre el síndrome mitocondrial de Kearns-Sayre y nuevas aproximaciones terapéuticas (farmacológicas y genéticas)
Principal investigator: Gloria GarrabouFunder: Fundación de Investigación Médica Mutua MadrileñaCode: AP183672023Duration: 01/08/2023 - 31/07/2025 -
Omics technology and organoids to identify novel biomarkers and therapeutics in personalized medicine for sporadic inclusion body myositis
Principal investigator: Josep M. Grau Junyent, Gloria GarrabouFunder: Instituto de Salud Carlos IIICode: PI21/00935Duration: 01/01/2022 - 31/12/2024 -
Recerca en malalties neuromusculars i malalties metabòliques hereditàries
Principal investigator: Gloria GarrabouFunder: Generalitat de CatalunyaCode: 2021-SGR-01423Duration: 01/01/2022 - 31/12/2024 -
Phenylketonuria: from chilhood to adults through brain functional connectomics, cardiovascular changes, metabolomic and intestinal microbiota characteristics
Principal investigator: Josep M. Grau JunyentFunder: Fundació La Marató de TV3Code: 202014-30Duration: 20/05/2021 - 19/05/2024 -
Miositis por cuerpos de inclusión esporádica: desarrollo de nuevos modelos celulares para la identificación de biomarcadores y estrategias terapéuticas.
Principal investigator: Josep M. Grau Junyent, Gloria GarrabouFunder: Instituto de Salud Carlos IIICode: PI18/00498Duration: 01/01/2019 - 31/12/2021